Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile
fda-device · Food and Drug Administration · Rule · Published 2012-02-06 · Effective 2012-02-06 · 77 FR 5696
Document
Document number
2012-2558
Federal Register citation
77 FR 5696
CFR reference
21 CFR 201
Type
Rule
Action
Final rule.
Category
fda-device
Sub-agency
Food and Drug Administration
Publication date
2012-02-06
Effective date
2012-02-06
HHS docket
Docket No. FDA-2006-N-0364
Abstract
The Food and Drug Administration (FDA) is adopting as a final rule, without change, the interim final rule that issued regulations permitting FDA Center Directors to grant exceptions or alternatives to certain regulatory labeling requirements applicable to human drugs, biological products, or medical devices that are or will be included in the Strategic National Stockpile (SNS). FDA is taking this action to complete the rulemaking initiated with the interim final rule.